The Bear Cave #340

Wolfpack Research reported Flotek Industries (FTK) lost a $400M contract, potentially halving its backlog. Fugazi Research criticized Aeva Technologies (AEVA) as a struggling startup. Bristlemoon Research argued Macy's (M) is overvalued. L3Harris (LHX) CEO departed over conduct violations. Ameresco (AMRC) CFO and GC resigned. Viking Therapeutics (VKTX) COO and Merit Medical (MMSI) COO departed. Boston Beer (SAM) CFO is stepping down. Edwin Dorsey predicts long-term trouble for DraftKings (DKNG)

Original reporting
Published Aug 23, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 23, 2026, 4:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Bear Cave #340 — source image
Decision brief

The 30-second read

$FTKBearishLow
01

Why it matters

Overall sentiment is negative due to multiple executive exits and critical research reports, suggesting short‑bias for affected tickers.

02

Market read

The article provides a collection of negative catalysts for several U.S. stocks, but offers no new primary disclosures.

03

What to watch

Potential hidden operational issues not disclosed in the brief.

Relevance 4/10Novelty 2/10Timing: none

Background

The Bear Cave newsletter aggregates recent activist research, executive departures, and opinion pieces.

Company-level read

Ticker impact

$FTKBearishMedium confidence
Context

Wolfpack Research alleges Flotek Industries failed to disclose the cancellation of a $400M PREPA contract, potentially wiping out over 50% of its backlog.

Expected impact

downside pressure

Evidence & confidence

Backlog loss of >50% is material for a $894M market cap company.

$AEVABearishMedium confidence
Context

Fugazi Research calls Aeva Technologies a "bleeding startup" and highlights $11.9M insider selling after its AI-data-center announcement.

Expected impact

downside risk

Evidence & confidence

Research report and insider sell signal weakness.

$MBearishLow confidence
Context

Bristlemoon Research labels Macy's as an "attractive short" despite recent comparable sales improvement.

Expected impact

potential decline

Evidence & confidence

Research opinion without new fundamentals.

$LHXBearishLow confidence
Context

L3Harris Technologies CEO resigned immediately after board discovered code‑of‑conduct violations.

Expected impact

possible dip

Evidence & confidence

CEO exit is material but impact uncertain.

$AMRCBearishLow confidence
Context

Ameresco CFO and CAO are stepping down within a month, with the General Counsel also resigning.

Expected impact

downside risk

Evidence & confidence

Leadership churn often pressures stock.

$VKTXBearishLow confidence
Context

Viking Therapeutics COO disappeared from the website with no disclosure.

Expected impact

potential decline

Evidence & confidence

Lack of transparency is a red flag.

$SAMNeutralLow confidence
Context

Boston Beer CFO announced his resignation effective September 30, with an interim CFO appointed.

Expected impact

minimal impact

Evidence & confidence

Routine CFO change without immediate financial effect.

$MMSINeutralLow confidence
Context

Merit Medical Systems COO gave notice to resign for good reason, effective March 2027 after his position was eliminated.

Expected impact

minimal impact

Evidence & confidence

Resignation effective years away.

Market effects

Activist reports may increase short‑interest in industrial and tech sectors.

No specific regional effect identified.

Limited to U.S. listed companies mentioned.

Counterpoint

Some investors may view the resignations as opportunities for fresh leadership.

Key entities

  • Wolfpack Research

    Published critical report on Flotek Industries.

  • Fugazi Research

    Published critical report on Aeva Technologies.

Related articles

$MHighAI 8/10

Macy’s Earnings Call Signals Turnaround Momentum

Macy's (M) reported Q2 earnings that surpassed expectations, with revenue up 1.1% to $4.9B and adjusted EPS at $0.63. Comparable sales rose 2.7% across Macy's, Bloomingdale's, and Bluemercury. Management highlighted margin expansion, cash flow improvements, and strategic initiatives, while raising full-year guidance. However, third-quarter outlook remains cautious with flat-to-slightly-negative comps and a small EPS loss.

$LHXHigh

L3Harris Is Down 30% and Guggenheim Calls It a Buy

L3Harris Technologies (LHX) gained 0.43% premarket after Guggenheim initiated coverage with a Buy rating and $365 price target, suggesting 49% upside. The stock is near its 52-week low, down 30% in six months. Guggenheim expects sustained growth and defense spending tailwinds. Jefferies started coverage at Hold with a $315 target, citing leadership changes and missile IPO uncertainty.

$AMRCHighAI 8/10

Ameresco’s (AMRC) Data Center Boom Masks A Cash Flow Problem

Ameresco (AMRC) reported record $1.8B in new project awards for Q2 2026, with $1.2B tied to data center power projects. Total backlog rose 32% YoY to $6.73B. However, net income fell to $9.7M ($0.18 per share) from $12.9M ($0.24) YoY, and the company posted a net loss of $8.6M for H1 2026. Management raised full-year Non-GAAP EPS guidance to $1.15-$1.35, citing tax benefits. Cash increased to $138.3M from $71.8M YoY.

$LHXHighAI 9/10

Should Rocket Motor Contract Require Action From L3Harris (LHX) Investors?

Lockheed Martin awarded L3Harris Technologies a $4.7b contract over seven years for PAC-3 MSE rocket motors. The deal supports L3Harris' propulsion segment and ties into new manufacturing facilities in Camden, Arkansas, expected to open in 2027. Analysts project $28.0b revenue and $3.0b earnings by 2029, with a 38% potential upside. Risks include margin management, debt, and U.S. budget decisions.